LW158 IMP Support (FAME)

The trial will be running in Cameroon and involves three oral drugs. Initial dose will be delivered to remote community clinic or healthcare facility and subsequent doses stored and given from the hospital site during the participant admission.

The purpose of this project is to appoint a supplier to handle the receipt of clinical trial Investigational Medicinal Product (IMP) from manufacturer, import, labelling, and distribution to the in-country sites/teams.